BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.
Condition(s):Telogen EffluviumLast Updated:July 8, 2022Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Telogen EffluviumLast Updated:July 8, 2022Not yet recruiting
Condition(s):Solid Malignancy; LymphomaLast Updated:November 29, 2023Recruiting
Condition(s):Endoscopic Ultrasonography; Pancreatic Disease; Bile Duct Diseases; Artificial IntelligenceLast Updated:June 22, 2023Recruiting
Condition(s):Health Behavior; Smartphone Addiction; Healthy NutritionLast Updated:January 3, 2022Recruiting
Condition(s):Cardiovascular Diseases; Type 2 DiabetesLast Updated:February 28, 2024Not yet recruiting
Condition(s):ToothlessLast Updated:February 15, 2024Recruiting
Condition(s):Cardiac Devices InfectionLast Updated:January 12, 2024Not yet recruiting
Condition(s):Alcohol Prevention; Harm ReductionLast Updated:November 15, 2023Not yet recruiting
Condition(s):Emotion Regulation; HealthyLast Updated:September 13, 2023Not yet recruiting
Condition(s):Primary AldosteronismLast Updated:September 11, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.